CDK2 and metastatic melanoma: Utilizing CRISPR-Cas9 genome editing, we generated models of ITGA3 loss in the murine melanoma YUMMER1.7 (BrafV600E/WT, Pten–/–, Cdkn2–/–) cell line and in the human metastatic melanoma SKmel147 cell line.